Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit

J Bone Miner Res. 2018 Mar;33(3):540-542. doi: 10.1002/jbmr.3369. Epub 2018 Feb 7.

Authors

Tomas Urbina^{1

2}, Rakiba Belkhir^{1

2}, Geoffrey Rossi^{1

2}, Franck Carbonnel¹, Stephan Pavy^{1

2}, Michael Collins¹, Xavier Mariette^{1

2}, Raphaèle Seror^{1

2}

Affiliations

¹ Assistance Publique-Hopitaux de Paris, Hôpitaux Universitaires Paris-Sud, Department of Rheumatology, Le Kremlin Bicêtre, France.
² Université Paris-Sud; INSERM U1184, Le Kremlin Bicêtre, France.

PMID: 29281120
DOI: 10.1002/jbmr.3369

No abstract available

Publication types

Letter
Comment

MeSH terms

Dietary Supplements
Fibroblast Growth Factor-23
Fibroblast Growth Factors
Fractures, Stress*
Gait
Humans
Hypophosphatemia*
Inflammatory Bowel Diseases*
Iron
Osteomalacia*
Pain

Substances

FGF23 protein, human
Fibroblast Growth Factors
Fibroblast Growth Factor-23
Iron